Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma

This publication has 43 references indexed in Scilit:

• RETRACTED: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1
  Biomedicine & Pharmacotherapy, 2018
• Expression of MRP1 and ABCG2 is associated with adverse clinical outcomes of papillary thyroid carcinoma with a solid component
  Human Pathology, 2017
• The Role of MicroRNAs in the Chemoresistance of Breast Cancer
  Drug Development Research, 2015
• MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2
  Cancer Letters, 2013
• Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma
  Cancer Letters, 2012
• MicroRNA‐206 Is Associated With Invasion and Metastasis of Lung Cancer
  The Anatomical Record, 2010
• Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005
  Cancer, 2009
• Changing Patterns in the Incidence and Survival of Thyroid Cancer with Follicular Phenotype—Papillary, Follicular, and Anaplastic: A Morphological and Epidemiological Study
  Endocrine Pathology, 2007
• Evidence for Transcriptional and Posttranscriptional Alterations of the Sodium/Iodide Symporter Expression in Hypofunctioning Benign and Malignant Thyroid Tumors
  The American Journal of Pathology, 2004
• The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
  Cell, 1993